Ap2A1 Gene plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.
Ap2A1 Gene is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
| AP-2 Complex Subunit Alpha 1 | |
|---|---|
| Gene Symbol | AP2A1 |
| Full Name | Adaptor Related Protein Complex 2 Subunit Alpha 1 |
| Chromosome | 19q13.33 |
| NCBI Gene ID | 160 |
| OMIM | 601026 |
| Ensembl ID | ENSG00000146938 |
| UniProt ID | O95782 |
| Associated Diseases | Alzheimer's Disease, Parkinson's Disease, Intellectual Disability |
AP2A1 encodes the alpha-2 subunit of the adaptor protein complex AP-2, a key component of clathrin-mediated endocytosis. AP-2 localizes to the plasma membrane and recruits cargo molecules, clathrin, and accessory proteins to form clathrin-coated vesicles. In neurons, AP-2 is essential for synaptic vesicle recycling, receptor internalization, and trafficking of neurotransmitter receptors. AP-2-mediated endocytosis regulates AMPA receptor trafficking during synaptic plasticity.
Ubiquitously expressed with high expression in brain. Enriched at presynaptic terminals and dendritic spines. Critical for neuronal viability.
| Disease | Variants | Inheritance | Mechanism |
|---|---|---|---|
| Alzheimer's Disease | Promoter variants | Risk factor | Impaired receptor trafficking |
| Parkinson's Disease | R635Q | Risk factor | Synaptic vesicle recycling deficits |
| Intellectual Disability | Missense | De novo | Developmental defects |
Ap2A1 Gene plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.
The study of Ap2A1 Gene has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.